Novel quinolines carrying pyridine, thienopyridine, isoquinoline, thiazolidine, thiazole and thiophene moieties as potential anticancer agents

Ghorab, Mostafa M.; Alsaid, Mansour S.; Al-Dosari, Mohammed S.; Ragab, Fatma A.; Al-Mishari, Abdullah A.; Almoqbil, Abdulaziz N.

doi:10.1515/acph-2016-0016

Abstract

As a part of ongoing studies in developing new anticancer agents, novel 1,2-dihydropyridine 4, thienopyridine 5, isoquinolines 6–20, acrylamide 21, thiazolidine 22, thiazoles 23–29 and thiophenes 33–35 bearing a biologically active quinoline nucleus were synthesized. The structure of newly synthesized compounds was confirmed on the basis of elemental analyses and spectral data. All the newly synthesized compounds were evaluated for their cytotoxic activity against the breast cancer cell line MCF7. 2,3-Dihydrothiazole-5-carboxamides 27, 25, 4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide (34), 1,2-dihydroisoquinoline-7-carbonitrile (7), 5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-3-carboxamide (35), 1,2-dihydroisoquinoline-7-carbonitrile (6), 2-cyano-3-(dimethylamino)-N-(quinolin-3-yl)acrylamide (21), 1,2-dihydroisoquinoline-7-carbonitriles (11) and (8) exhibited higher activity (IC₅₀ values of 27–45 μmol L^–1) compared to doxorubicin (IC₅₀ 47.9 μmol L^–1). LQ quinolin-3-yl)-1,2-dihydroisoquinoline-7-carbonitrile (12), 2-thioxo-2,3-dihydrothiazole-5-carboxamide (28) and quinolin-3-yl)-1,2-dihydroisoquinoline-7-carbonitrile (15) show activity comparable to doxorubicin, while (quinolin-3-yl)-1,2-dihydroisoquinoline-7-carbonitrile (9), 2,3-dihydrothiazole-5-carboxamide (24), thieno [3,4-c] pyridine-4(5H)-one (5), cyclopenta[b]thiophene-3-carboxamide (33) and (quinolin-3-yl)-6-stryl-1,2-dihydroisoquinoline-7-carbonitrile (10) exhibited moderate activity, lower than doxorubicin.

References

1. H. Frankish, 15 Million new cancer cases per year by 2020, says WHO, Lancet361 (2003) 1278–1287; DOI: 10.1016/S0140-6736(03)13038-3.10.1016/S0140-6736(03)13038-3
Search in Google Scholar
2. K. Kubo, T. Shimizu, S. I. Ohyama, H. Murooka, A. Iwai, K. Nakamura, K. Hasegawa, Y. Kobayashi, N. Takahashi, K. Takahashi, S. Kato, T. Izawa and T. Isoe, Novel potent orally active selective VEGFR-2 tyrosine kinase inhibitors: synthesis, structure-activity relationships, and antitumor activities of N-phenyl-N’-{4-(4-quinolyloxy)phenyl}-ureas, J. Med. Chem. 48 (2005) 1359–1366; DOI: 10.1021/jm030427r.10.1021/jm030427r
Search in Google Scholar
3. R. O’Connor, Mdm–mediated ubiquitylation: P53 and beyond, a review of mechanisms of circumvention and modulation of chemotherapeutic drug resistance, Curr. Cancer Drug Targets9 (2009) 273–280; DOI: 10.2174/156800909788166583.10.2174/156800909788166583
Search in Google Scholar
4. C. Hu, V. R Solomon and G. L. Ulibarri, The efficacy and selectivity of tumor cell killing by AKT inhibitors are substantially increased by chloroquin, Bioorg. Med. Chem. 16 (2008) 7888–7893; DOI: 10.1016/j.bmc.2008.07.076.10.1016/j.bmc.2008.07.076
Search in Google Scholar
5. Y. C. Mayur, G. J. Peters, V. V. Prasad, C. Lemo and N. K. Sathish, Design of new drug molecules to be used in reversing multidrug resistance in cancer, Curr. Cancer Drug Targets9 (2009) 298–306; DOI: 10.2174/156800909788166619.10.2174/156800909788166619
Search in Google Scholar
6. M. G. Ferlin, B. Gatto, G. Chiarelotto and M. Palumbo, Pyrroloquinoline derivatives as potential antineoplastic drugs, Bioorg. Med. Chem.8 (2000) 1415–1422; DOI: 10.1016/S0968-0896(00)00060-2.10.1016/S0968-0896(00)00060-2
Search in Google Scholar
7. M. S. Alsaid, M. S. Bashandy, S. I. Al-Qasoumi and M. M. Ghorab, Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives, Eur. J. Med. Chem.46 (2011) 137–141; DOI: 10.1016/j.ejmech.2010.10.024.10.1016/j.ejmech.2010.10.024
Search in Google Scholar
8. S. Pédeboscq, D. Gravier, F. Casadebaig, G. Hou, A. Gissot, F. De. Giorgi, F. Ichas, J. Cambar and J. P. Pometan, Synthesis and study of antiproliferative activity of novel thienopyrimidines on glioblastoma cells, Eur. J. Med. Chem.45 (2010) 2473–2479; DOI:10.1016/j.ejmech.-2010.02.032.
Search in Google Scholar
9. R. L. Weinkauf, A. Y. Chen, C. Yu, L. Liu, L. Barrows and E. J. LaVoie, Antineoplastic activity of benzimidazo[1,2-b] isoquinolines, indolo[2,3-b]quinolines, and pyridocarbazoles, Bioorg. Med. Chem.2 (1994) 781–786; DOI: 10.1016/S0968-0896(00)82177-X.10.1016/S0968-0896(00)82177-X
Search in Google Scholar
10. S. Li, Z. Yao, Y. Zhao, W. Chen, H. Wang, X. Kuang, W. Zhan, S. Yao, S. Yu and W. Hu, Design, synthesis and biological evaluation of novel acrylamide analogues as inhibitors of BCR-ABL kinase, Bioorg. Med. Chem. Lett. 22 (2012) 5279–5282; DOI: 10.1016/j.bmcl.2012.06.044.10.1016/j.bmcl.2012.06.04422789429
Search in Google Scholar
11. F. E. Onen-Bayram, I. Durmaz, D. Scherman, J. Herscovici and R. Cetin-Atalay, A novel thiazolidine compound induces caspase-9 dependent apoptosis in cancer cells, Bioorg. Med. Chem.20 (2012) 5094–5102; DOI: 10.1016/j.bmc.2012.07.016.10.1016/j.bmc.2012.07.01622867707
Search in Google Scholar
12. G. J. Atwell, C. D. Bos, B. C. Baguley and W. A. Denny, Potential antitumor agents. 56. “Minimal” DNA-intercalating ligands as antitumor drugs: phenylquinoline-8-carboxamides, J. Med. Chem. 3 (1988) 1048–1052; DOI: 10.1021/jm00400a029.10.1021/jm00400a029
Search in Google Scholar
13. G. J. Atwell, B. C. Baguley and W. A. Denny, Potential antitumor agents. 57. 2-phenylquinoline-8-carboxamides as minimal DNA-intercalating antitumor agents with in vivo solid tumor activity, J. Med. Chem. 32 (1989) 396–401; DOI: 10.1021/jm00122a018.10.1021/jm00122a018
Search in Google Scholar
14. T. Suzuki, N. Fukazawa, K. San-nohe, W. Sato, O. Yano and T. Tsuruo, Structure activity relationship of newly synthesized quinoline derivatives for reversal of multidrug resistance in cancer, J. Med. Chem. 40 (1997) 2047–2052; DOI: 10.1021/jm960869l.10.1021/jm960869l
Search in Google Scholar
15. Y. H. Wang, T. Motoji, S. Motomura, N. Shiozaki, T. Tsuruo and H. Mizoguchi, Multi-drug resistance-reversing agent, on acute myelogenous leukaemic blasts and K562 cells resistant to adriamycin cell line, Eur. J. Haematol. 58 (1997) 186–194; DOI: 10.1111/j.1600-0609.1997.tb00946.x.10.1111/j.1600-0609.1997.tb00946.x
Search in Google Scholar
16. H. Zhao, Y. Cai, S. Santi, R. Lafrenie and H. Lee, Chloroquine-mediated radiosensitization is due to the destabilization of the lysosomal membrane and subsequent induction of cell death by necrosis, Radiat. Res. 164 (2005) 250–257; DOI: 10.1667/RR3436.1.10.1667/RR3436.1
Search in Google Scholar
17. H. Zhang, V. R. Solomon, C. Hu, G. Ulibarri and H. Lee, Synthesis and in vitro cytotoxicity evaluation of 4-aminoquinoline derivatives, Biomed. Pharmacother.62 (2008) 65–69; DOI: 10.1016/j.biopha.2007.04.007.10.1016/j.biopha.2007.04.007
Search in Google Scholar
18. V. R. Solomon and H. Lee, Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies, Eur. J. Pharmacol. 625 (2009) 220–233; DOI: 10.1016/j.ejphar.2009.06.063.10.1016/j.ejphar.2009.06.063
Search in Google Scholar
19. M. S. Al-Said, M. G. El-Gazzar, M. S. Al-Dosari and M. M. Ghorab, Synthesis, anticancer activity and radiosensitizing evaluation of some new 2-pyridone derivatives, Arzneimittel-Forsch.62 (2012) 149–156; DOI: 10.1055/s-0031-1299695.10.1055/s-0031-1299695
Search in Google Scholar
20. P. Fossa, G. Menozzi, P. Dorigo, M. Floreani and L. Mosti, Synthesis and pharmacological characterization of functionalized 2-pyridones structurally related to the cardiotonic agent milrinone, Bioorg. Med. Chem.11 (2003) 4749–4759; DOI: 10.1016/S0968-0896(03)00528-5.10.1016/S0968-0896(03)00528-5
Search in Google Scholar
21. W. Chen, P. Zhan, D. Rai, E. De Clercq, C. Pannecouque, J. Balzarini, Z. Zhou, H. Liu and X. Liu, Discovery of 2-pyridone derivatives as potent HIV-1 NNRTIs using molecular hybridization based on crystallographic overlays, Bioorg. Med. Chem.22 (2014) 1863–1872; DOI: 10.1016/j.bmc.2014.01.054.10.1016/j.bmc.2014.01.05424581546
Search in Google Scholar
22. M. M. Ghorab, Z. H. Ismail, M. Abdalla and A. A. Radwan, Synthesis, antimicrobial evaluation and molecular modelling of novel sulfonamides carrying a biologically active quinazoline nucleus, Arch. Pharm. Res. 36 (2013) 660–670; DOI: 10.1007/s12272-013-0094-6.10.1007/s12272-013-0094-623529860
Search in Google Scholar
23. M. S. Al-Dosari, M. M. Ghorab, M. S. Alsaid and M. Y. Nissan, Discovering some novel 7-chloroquinolines carrying a biologically active benzenesulfonamide moiety as a new class of anticancer agents, Chem. Pharm. Bull. 61 (2013) 50–58; DOI: 10.1248/cpb.c12-00812.10.1248/cpb.c12-0081223302586
Search in Google Scholar
24. M. S. Alsaid, M. S. Bashandy and M. M. Ghorab, Novel quinolines bearing a biologically active trimethoxyphenyl moiety as a new class of antitumor agents, Arzneimittel-Forsch. 61 (2011) 527–531; DOI: 10.1055/s-0031-1296239.10.1055/s-0031-129623922029230
Search in Google Scholar
25. M. S. Bashandy, M. S. Al-Said, S. I. Al-Qasoumi and M. M. Ghorab, Design and synthesis of some novel hydrazide, 1, 2-dihydropyridine, chromene derivatives carrying biologically active sulfone moieties with potential anticancer activity, Arzneimittel-Forsch. 61 (2011) 521–526; DOI: 10.1055/s-0031-1296238.10.1055/s-0031-129623822029229
Search in Google Scholar
26. M. M. Ghorab, M. S. Al-Said and E. M. El-Hossary, In vitro cytotoxic evaluation of some new heterocyclic sulfonamide derivatives, J. Heterocycl. Chem.48 (2011) 563–571; DOI: 10.1002/jhet.619.10.1002/jhet.619
Search in Google Scholar
27. M. S. Al-Said, M. S. Bashandy, S. I. Al-Qasoumi and M. M. Ghorab, Anti-breast cancer activity of some novel 1,2-dihydropyridine, thiophene and thiazole derivatives, Eur. J. Med. Chem. 46 (2011) 137–141; DOI: 10.1016/j.ejm-ech.2010.10.024.
Search in Google Scholar
28. M. M. Ghorab, F. A. Ragab, H. I. Heiba, R. K. Arafa and E. M. El-Hossary, Docking study, in vitro anticancer screening and radiosensitizing evaluation of some new fluorine-containing quinoline and pyrimidoquinoline derivatives bearing a sulfonamide moiety, Med. Chem. Res.20 (2011) 388–400; DOI: 10.1007/s00044-010-9332-3.10.1007/s00044-010-9332-3
Search in Google Scholar
29. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J. T. Warren, H. Bokesch, S. Kenny and M. R. Boyd, New colorimetric cytotoxicity assay for anticancer-drug screening, J. Natl. Cancer. Inst. 82 (1990) 1107–1112; DOI: 10.1093/jnci/82.13.1107.10.1093/jnci/82.13.11072359136
Search in Google Scholar
30. M. M. Ghorab, M. S. Alsaid, H. A. Ghabour and H.-K. Fun, Synthesis, crystal structure and antitumor activity of novel 2-cyano-N-(quinolin-3-yl) acetamide, Asian J. Chem. 26 (2014) 7389–7392; DOI:10.14233/ajchem.2014.17050.10.14233/ajchem.2014.17050
Search in Google Scholar

Novel quinolines carrying pyridine, thienopyridine, isoquinoline, thiazolidine, thiazole and thiophene moieties as potential anticancer agents

Abstract

Paradigm

My account